Citizens reiterates Charles Schwab stock rating on business momentum

Citizens maintained its Market Outperform rating on Charles Schwab and a $120 price target, despite lowering the valuation multiple applied to its 2027 EPS estimate from 16.5x to 16x. Schwab’s third-quarter 2026 adjusted EPS of $1.69 beat the $1.66 estimate and rose 29% year over year, while $7.17 billion in revenue fell slightly short of the $7.2 billion forecast. Citizens cited asset gathering and franchise momentum but acknowledged pressure from lower-than-expected net interest margin and increased wholesale funding.

Analysis

The investment debate is less about headline EPS and more about whether Schwab can convert asset gathering into durable, low-cost funding before wholesale funding and cash sorting keep net interest margin under pressure. If client assets continue to accumulate but migrate away from sweep deposits, growth may support fee revenue without fixing the near-term earnings mix; that would limit multiple recovery even if reported EPS remains strong. Conversely, improving deposit retention alongside asset growth would validate operating leverage and make the current AI-related valuation concern look more like sentiment than impaired economics.

Over the next 1–3 months, watch deposit mix, wholesale funding reliance, and net interest margin guidance—not just total asset flows or adjusted EPS. Over 6–18 months, platform monetization and advice adoption could support fee diversification, while AI could both lower service costs and commoditize routine advice; the net effect is not yet established. Morgan Stanley and other wealth platforms are relevant competitive benchmarks, but the article provides no evidence of direct share gains or losses.

The cited valuation case depends on a 2027 earnings estimate and a chosen multiple; neither establishes fair value. The apparent low multiple may persist if funding costs stay elevated or the market doubts earnings quality. Citizens’ rating is an analyst view, not a catalyst attributable to Citizens Financial Group (CFG); the article gives no basis for a CFG trade.

Key Decisions for Investors

• Consider a staged, modest long in SCHW only if upcoming disclosures show asset gathering accompanied by stable or improving sweep-deposit retention and net interest margin. Treat the analyst target as a scenario, not a price anchor.
• Keep the position thesis falsifiable: reduce or exit if wholesale funding reliance rises while NIM guidance deteriorates, or if asset growth fails to translate into stronger fee revenue and operating leverage.
• For the next earnings cycle, track deposit mix, cash sorting, funding costs, and advice-related revenue alongside EPS. A revenue beat alone would not confirm the balance-sheet thesis.
• Do not use CFG as a proxy for the analyst upgrade: Citizens is identified as the rating source, and no Citizens Financial Group operating news or investment catalyst is supplied.